AbbVie Inc. (ABBV) Cash flow statement
Top 10 of 23 line items reported by ABBV · 250+ in the full API →
AbbVie Inc. (ABBV) · Cash Flow Statement
Consolidated Statements of Cash Flows
Annual · In millions USD, except per-share data · Latest filed Feb 20, 2026 · FY ends Dec 31
| Fiscal Years Ended | |||||
|---|---|---|---|---|---|
FY2025 Dec 31, 2025 | FY2024 Dec 31, 2024 | FY2023 Dec 31, 2023 | FY2022 Dec 31, 2022 | Trend | |
| Net Cash Flow from Operating Activities | $19,030 | $18,806 | $22,839 | $24,943 | |
| Net Income | 4,226 | 4,278 | 4,863 | 11,836 | |
| Net Cash Flow from Investing Activities | $(6,643) | $(20,820) | $(2,009) | $(623) | |
| Capital Expenditures | -1,214 | -974 | -777 | -695 | |
| Other Investing Activities | -29 | (-189) | (-13) | (-774) | |
| Net Cash Flow from Financing Activities | $(12,724) | $(5,211) | $(17,222) | $(24,803) | |
| Common stock repurchased | -980 | -1,708 | -1,972 | -1,487 | |
| Other financing activities | 68 | 57 | 48 | 30 | |
| Net Cash Flow | $(295) | $(7,290) | $3,613 | $(545) | |
| Free Cash Flow | 17,816 | 17,832 | 22,062 | 24,248 | |
13 more line items available via the API
Depreciation & AmortizationStock-Based CompensationAccounts receivableInventoriesOther current assetsAccounts payableNet Debt Issued (Repaid)Total debt issuedShort-term debt issuedLong-term debt issuedTotal debt repaidShort-term debt repaidLong-term debt repaid